Lack of association between aortic sclerosis and left ventricular hypertrophy in elderly subjects

Angus K Nightingale1, Aaron L Sverdlov, Sharmalar Rajendran

  • 1Department of Cardiology, The Queen Elizabeth Hospital, University of Adelaide, Adelaide, Australia; Bristol Heart Institute, Bristol, UK.

Insights

Aortic sclerosis, a condition affecting aging adults, was not linked to increased left ventricular mass in this study. This finding suggests aortic sclerosis does not cause left ventricular hypertrophy in individuals without hypertension or prior cardiovascular disease.

Area of Science:

  • Cardiology
  • Gerontology
  • Vascular Biology

Background:

  • Aortic sclerosis is linked to increased left ventricular (LV) mass, especially in hypertensive individuals.
  • Endothelial dysfunction associated with aortic sclerosis may independently stimulate left ventricular hypertrophy.
  • The role of aortic sclerosis in LV mass determination in non-hypertensive aging populations remains unclear.

Purpose of the Study:

  • To investigate whether aortic sclerosis is a determinant of increased left ventricular mass.
  • To assess the relationship between aortic sclerosis and left ventricular hypertrophy in aging, normotensive subjects.
  • To explore potential independent pathways linking aortic sclerosis to cardiac remodeling.

Main Methods:

  • Studied 79 non-hypertensive subjects (mean age 68 ± 6 years) without prior cardiovascular disease.
  • Assessed LV mass using cardiac MRI and indexed to height(2.7).
  • Evaluated aortic sclerosis via echocardiography (aortic valve backscatter) and endothelial function markers.

Main Results:

  • Aortic sclerosis was present in 19% of subjects, with no significant difference in LV mass compared to those without.
  • LV mass correlated with systolic blood pressure, independently of aortic sclerosis.
  • Multivariate analysis identified male gender, systolic blood pressure, and BMI as correlates of LV mass, but not aortic sclerosis.

Conclusions:

  • Aortic sclerosis is not associated with left ventricular hypertrophy in this cohort.
  • The study population was aging, normotensive, and free of established cardiovascular disease.
  • Findings suggest aortic sclerosis is not a direct driver of LV hypertrophy in this specific demographic.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...